Literature DB >> 2064997

Subcellular localization of the retinoblastoma protein.

L Szekely1, E Uzvolgyi, W Q Jiang, M Durko, K G Wiman, G Klein, J Sumegi.   

Abstract

The subcellular localization of the retinoblastoma (RB) protein has been studied in primate cell lines by immunofluorescence staining using different monoclonal and polyclonal antibodies. The protein appeared as granules of heterogeneous size over the interphase nuclei. Computer assisted digital overlap analysis indicated that it was predominantly localized in euchromatic areas with low DNA density. The largest RB positive grains lined up on the heterochromatin/euchromatin boundary. During mitosis, the RB protein dissociated from the condensing chromosomes. It was dispersed throughout the cytoplasm during metaphase and anaphase, and it reassociated with the decondensing chromatin during telophase. A new monoclonal antibody, designated aRB1C1, was raised against a bacterial TrpE/human retinoblastoma protein. It specifically recognized the nonphosphorylated and differentially phosphorylated forms of the RB protein in immunoprecipitation experiments. A collection of RB expressing cell lines gave a positive staining reaction with the antibody, whereas the RB negative Weri-RB-27 retinoblastoma and OHS osteosarcoma cells failed to react. Wild-type RB complementary DNA was introduced into Weri-RB-27 by retrovirus mediated gene transfer. Similar experiments were performed with the DU145 prostatic carcinoma cell line that expresses a mutant RB protein. Reconstituted cells of both lines expressed the normal size RB protein and gave a positive immunofluorescence reaction with the aRB1C1 and other anti-RB antibodies. The new monoclonal antibody, however, showed cell type dependent differences of the staining pattern compared to other anti-RB antibodies, suggesting differentiation dependent accessibility to its epitope.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2064997

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  14 in total

1.  Regulation of the Chlamydomonas cell cycle by a stable, chromatin-associated retinoblastoma tumor suppressor complex.

Authors:  Bradley J S C Olson; Michael Oberholzer; Yubing Li; James M Zones; Harjivan S Kohli; Katerina Bisova; Su-Chiung Fang; Jill Meisenhelder; Tony Hunter; James G Umen
Journal:  Plant Cell       Date:  2010-10-26       Impact factor: 11.277

2.  The chromo superfamily: new members, duplication of the chromo domain and possible role in delivering transcription regulators to chromatin.

Authors:  E V Koonin; S Zhou; J C Lucchesi
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

3.  Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent.

Authors:  V V Ogryzko; T H Hirai; V R Russanova; D A Barbie; B H Howard
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

4.  The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein.

Authors:  M Alcalay; L Tomassoni; E Colombo; S Stoldt; F Grignani; M Fagioli; L Szekely; K Helin; P G Pelicci
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

5.  Structure of the chromatin binding (chromo) domain from mouse modifier protein 1.

Authors:  L J Ball; N V Murzina; R W Broadhurst; A R Raine; S J Archer; F J Stott; A G Murzin; P B Singh; P J Domaille; E D Laue
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

6.  A bipartite nuclear localization signal in the retinoblastoma gene product and its importance for biological activity.

Authors:  E Zacksenhaus; R Bremner; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

7.  Id2 promotes apoptosis by a novel mechanism independent of dimerization to basic helix-loop-helix factors.

Authors:  M Florio; M C Hernandez; H Yang; H K Shu; J L Cleveland; M A Israel
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

8.  EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.

Authors:  L Szekely; G Selivanova; K P Magnusson; G Klein; K G Wiman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

9.  Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif.

Authors:  Grant A Darnell; Toni M Antalis; Ricky W Johnstone; Brett W Stringer; Steven M Ogbourne; David Harrich; Andreas Suhrbier
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

10.  Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus.

Authors:  Y Liu; L Szekely; D Grandér; S Söderhäll; G Juliusson; G Gahrton; S Linder; S Einhorn
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.